Literature DB >> 32475247

Patterns of cartilage loss and anterior cruciate ligament status in end-stage osteoarthritis of the knee.

Chloe E H Scott1, George Holland2, Oliver Krahelski3, Iain R Murray4, John F Keating5, Oisin J F Keenan6.   

Abstract

AIMS: This study aims to determine the proportion of patients with end-stage knee osteoarthritis (OA) possibly suitable for partial (PKA) or combined partial knee arthroplasty (CPKA) according to patterns of full-thickness cartilage loss and anterior cruciate ligament (ACL) status.
METHODS: A cross-sectional analysis of 300 consecutive patients (mean age 69 years (SD 9.5, 44 to 91), mean body mass index (BMI) 30.6 (SD 5.5, 20 to 53), 178 female (59.3%)) undergoing total knee arthroplasty (TKA) for Kellgren-Lawrence grade ≥ 3 knee OA was conducted. The point of maximal tibial bone loss on preoperative lateral radiographs was determined as a percentage of the tibial diameter. At surgery, Lachman's test and ACL status were recorded. The presence of full-thickness cartilage loss within 16 articular surface regions (two patella, eight femoral, six tibial) was recorded.
RESULTS: According to articular cartilage loss and ACL status, 195/293 (67%) were suitable for PKA or CPKA: medial unicompartmental knee arthroplasty (UKA) 97/293 (33%); lateral UKA 25 (9%); medial bicompartmental arthroplasty 31 (11%); lateral bicompartmental arthroplasty 12 (4%); bicondylar-UKA 23 (8%); and patellofemoral arthroplasty (PFA) seven (2%). The ACL was intact in 166 (55%), frayed in 82 (27%), disrupted in 12 (4%), and absent in 33 (11%). Lachman testing was specific (97%) but poorly sensitive (38%) for disrupted/absent ACLs. The point of maximal tibial bone loss showed good interclass correlation (ICC 0.797, 0.73 to 0.85 95% confidence interval (CI); p < 0.001) and was more posterior when the ACL was absent. Maximum tibial bone loss occurring at > 55% of the anterior to posterior distance predicted ACL absence with 93% sensitivity and 91% specificity (area under the curve 0.97 (0.94 to 0.99 95% CI; p < 0.001).
CONCLUSION: ACL status can be reliably determined from a lateral radiograph using the location of maximal tibial bone loss. According to regions of cartilage loss and ACL status, two-thirds of patients with end-stage knee OA could potentially be treated with PKA or CPKA. Cite this article: Bone Joint J 2020;102-B(6):716-726.

Entities:  

Keywords:  Anterior cruciate ligament; Osteoarthritis; Partial knee arthroplasty

Mesh:

Year:  2020        PMID: 32475247     DOI: 10.1302/0301-620X.102B6.BJJ-2019-1434.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  4 in total

1.  A radiographic model predicting the status of the anterior cruciate ligament in varus knee with osteoarthritis.

Authors:  Changquan Liu; Juncheng Ge; Cheng Huang; Weiguo Wang; Qidong Zhang; Wanshou Guo
Journal:  BMC Musculoskelet Disord       Date:  2022-06-22       Impact factor: 2.562

2.  Loss to patient-reported outcome measure follow-up after hip arthroplasty and knee arthroplasty : patient satisfaction, associations with non-response, and maximizing returns.

Authors:  Lauren A Ross; Sara C O'Rourke; Gemma Toland; Deborah J MacDonald; Nick D Clement; Chloe E H Scott
Journal:  Bone Jt Open       Date:  2022-04

3.  Discovery of Lijianmin-Chengkun Complexes and Their Oncological Application in Osseous and Intraarticular Lesions Around the Knee.

Authors:  Xianhao Shao; Jianmin Li; Ailin Zhang; Yuan Yao; Feifei Sun; Zhenzhong Li; Tao Liu; Haiqing Hou; Qiuyao Li; Zhenfeng Li; Xiaofei Gao; Qiang Yang; Yuchun Li; Ka Li; Kun Cheng
Journal:  Front Surg       Date:  2021-12-03

4.  Effect of secretory leucocyte protease inhibitor on early tendon-to-bone healing after anterior cruciate ligament reconstruction in a rat model.

Authors:  Yongmao Wu; Yan Shao; Denghui Xie; Jianying Pan; Huabin Chen; Juncheng Yao; Jiarong Liang; Haolin Ke; Daozhang Cai; Chun Zeng
Journal:  Bone Joint Res       Date:  2022-07       Impact factor: 4.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.